HCA Healthcare Inc (HCA):企業の財務・戦略的SWOT分析

◆英語タイトル:HCA Healthcare Inc (HCA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH29920FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:71
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

HCA Healthcare Inc (HCA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

HCA Healthcare Inc (HCA) is a health care services company that provides a wide range of services in specialties including general surgery, internal medicine, cardiology, oncology, neurosurgery, orthopaedics and obstetrics. It also offers outpatient and ancillary health care services, diagnostic and emergency services and mental health care services. The company operates a network of hospitals; freestanding surgery and endoscopy centers and emergency care facilities; diagnostic and imaging centers; radiation and oncology therapy centers; comprehensive rehabilitation and physical therapy centers; and various other facilities. It operates facilities in the US and the UK. HCA is headquartered in Nashville, Tennessee, the US.

HCA Healthcare Inc Key Recent Developments

Mar 31,2021: HCA Healthcare, Inc. 1st Quarter 2021 Earnings Conference Call
Feb 25,2021: Brookdale to divest 80% stake in Brookdale Health Care Services for $400m
Feb 23,2021: HCA Healthcare named a 2021 World’s Most Ethical Company
Feb 18,2021: HCA Healthcare, Inc. to Present at February and March Healthcare Conferences
Feb 02,2021: HCA Healthcare reports fourth quarter 2020 results and provides 2021 guidance

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
HCA Healthcare Inc – Key Facts
HCA Healthcare Inc – Key Employees
HCA Healthcare Inc – Key Employee Biographies
HCA Healthcare Inc – Major Products and Services
HCA Healthcare Inc – History
HCA Healthcare Inc – Company Statement
HCA Healthcare Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
HCA Healthcare Inc – Business Description
Product Category: Managed Care and Other Insurers
Performance
Product Category: Managed Medicaid
Performance
Product Category: Managed Medicare
Performance
Product Category: Medicaid
Performance
Product Category: Medicare
Performance
Product Category: Other
Performance
Geographical Segment: American Group
Target Markets
Performance
Key Stats
Geographical Segment: Corporate and Other Group
Target Markets
Performance
Key Stats
Geographical Segment: National Group
Target Markets
Performance
Key Stats
HCA Healthcare Inc – Corporate Strategy
HCA Healthcare Inc – SWOT Analysis
SWOT Analysis – Overview
HCA Healthcare Inc – Strengths
HCA Healthcare Inc – Weaknesses
HCA Healthcare Inc – Opportunities
HCA Healthcare Inc – Threats
HCA Healthcare Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
HCA Healthcare Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 31, 2021: HCA Healthcare, Inc. 1st Quarter 2021 Earnings Conference Call
Feb 25, 2021: Brookdale to divest 80% stake in Brookdale Health Care Services for $400m
Feb 23, 2021: HCA Healthcare named a 2021 World’s Most Ethical Company
Feb 18, 2021: HCA Healthcare, Inc. to Present at February and March Healthcare Conferences
Feb 02, 2021: HCA Healthcare reports fourth quarter 2020 results and provides 2021 guidance
Jan 26, 2021: HCA Healthcare uses its COVID-19 registry by forming consortium with AHRQ and research institutions to accelerate COVID-19 research
Jan 21, 2021: HCA Healthcare invests in domestic production of PPE
Jan 14, 2021: HCA Healthcare 4th quarter 2020 earnings conference call
Dec 07, 2020: Mitch Edgeworth appointed President of HCA Healthcare’s TriStar Division
Oct 26, 2020: HCA Healthcare reports third quarter 2020 results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
HCA Healthcare Inc, Key Facts
HCA Healthcare Inc, Key Employees
HCA Healthcare Inc, Key Employee Biographies
HCA Healthcare Inc, Major Products and Services
HCA Healthcare Inc, History
HCA Healthcare Inc, Other Locations
HCA Healthcare Inc, Subsidiaries
HCA Healthcare Inc, Joint Venture
HCA Healthcare Inc, Key Competitors
HCA Healthcare Inc, Ratios based on current share price
HCA Healthcare Inc, Annual Ratios
HCA Healthcare Inc, Annual Ratios (Cont...1)
HCA Healthcare Inc, Annual Ratios (Cont...2)
HCA Healthcare Inc, Interim Ratios
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
HCA Healthcare Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
HCA Healthcare Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[HCA Healthcare Inc (HCA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AIA Group Limited:企業のM&A・事業提携・投資動向
    AIA Group Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AIA Group Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Jura Energy Corp (JEC):企業の財務・戦略的SWOT分析
    Jura Energy Corp (JEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Inter Pipeline Ltd (IPL):企業の財務・戦略的SWOT分析
    Inter Pipeline Ltd (IPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Banco Daycoval SA:企業の戦略・SWOT・財務情報
    Banco Daycoval SA - Strategy, SWOT and Corporate Finance Report Summary Banco Daycoval SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Tufts Medical Center:製薬・医療:M&Aディール及び事業提携情報
    Summary Tufts Medical Center (TMC), formerly New England Medical Center Hospital Inc, a subsidiary of Tufts University School of Medicine, is an academic medical center that provides patient care services. The center offers treatments for brain tumor, breast cancer, cardiac arrhythmia, cardiomyopath …
  • Excelsior Medical Co Ltd (4104)-医療機器分野:企業M&A・提携分析
    Summary Excelsior Medical Co., Ltd. (Excelsior Medical), formerly Enfield Medical Co., Ltd. is a medical equipment manufacturer that develops and markets products for intraluminal catheter care. The company’s products include SwabCap, SwabFlush, SwabKIT, ZR syringes, flush syringes, PharmAssist and …
  • Matrix Composites & Engineering Ltd (MCE):企業の財務・戦略的SWOT分析
    Summary Matrix Composites & Engineering Ltd (Matrix) is a manufacturer and supplier of engineered products and services. The company manufactures and distributes engineered products for developing and utilizing advanced composite and polymer materials technologies. Its products include well construc …
  • Divergent Energy Services Corp (DVG):石油・ガス:M&Aディール及び事業提携情報
    Summary Divergent Energy Services Corp (Divergent Energy), formerly CDN Oilfield Technologies and Solutions Corp is an energy service company that offers artificial lift technologies for the oil and gas industry. The company offers products such as electromagnetic submersible pumps and electric subm …
  • Cardax Inc (CDXI):製薬・医療:M&Aディール及び事業提携情報
    Summary Cardax Inc (Cardax), formerly Cardax Pharmaceuticals Inc is a life science company that discovers and develops pharmaceutical and consumer health technologies. The company discovers and develops anti-inflammatory dietary supplements, small molecule therapies, medicinal products, and drug pro …
  • Delta NV-エネルギー分野:企業M&A・提携分析
    Summary Delta N.V. (Delta) is an independent multi-utility company. It provides energy, network and infrastructure services, and digital services. The company generates electricity, transmits and trades in energy, and supplies gas and power. Delta provides cable services for both analogue and digita …
  • Ameren Corp (AEE):企業の財務・戦略的SWOT分析
    Ameren Corp (AEE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Gemphire Therapeutics Inc (GEMP):製薬・医療:M&Aディール及び事業提携情報
    Summary Gemphire Therapeutics Inc (Gemphire), formerly Michigan Life Therapeutics LLC, is a clinical stage biopharmaceutical company that develops and commercializes therapies for patients with cardiometabolic disorders, including dyslipidemia and non-alcoholic steatohepatitis (NASH). Its lead produ …
  • SPAGO Nanomedical AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Spago Nanomedical AB (Spago Nanomedical), formerly Spago Imaging AB is a research and development company that develops nanomedical products for the diagnosis and treatment of cancer. The company offers spagopix, a magnetic resonance imaging contrast agent to improve the visualization of sof …
  • Santhera Pharmaceuticals Holding AG (SANN):製薬・医療:M&Aディール及び事業提携情報
    Summary Santhera Pharmaceuticals Holding AG (Santhera) develops and commercializes novel pharmaceutical products indicated for patients with mitochondrial and neuromuscular diseases. It specifically focuses in the area of neuromuscular and neuro-ophthalmological conditions. The company’s lead produc …
  • EnBW Energie Baden-Wurttemberg AG (EBK):電力:M&Aディール及び事業提携情報
    Summary EnBW Energie Baden-Wurttemberg AG (EnBW) is an integrated energy company. Through its subsidiaries, the company generates, procures, transmits, and supplies electricity; and produces, transports and supplies gas. It produces electricity in coal, gas, pumped storage, and nuclear power plants. …
  • Central Japan Railway Company:企業の戦略・SWOT・財務情報
    Central Japan Railway Company - Strategy, SWOT and Corporate Finance Report Summary Central Japan Railway Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Dako AS-製薬・医療分野:企業M&A・提携分析
    Summary Dako A/S (Dako Denmark), a subsidiary of Agilent Technologies Inc is a diagnostic company. The company’s products include diagnostic antibodies, reagents and kits, software related products, instruments and related products, clone products, and synonym products. It also provides immunohistoc …
  • Georgia Power Co:企業の発電所・SWOT分析2018
    Georgia Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Prothena Corp Plc (PRTA):企業の財務・戦略的SWOT分析
    Summary Prothena Corp Plc (Prothena) discovers and develops therapies for the treatment of neurological disorders. It is evaluating Prasinezumab (PRX002/RG7935), a monoclonal antibody targeting alpha-synuclein protein, against Parkinson’s disease and other related synucleinopathies; and PRX004, an i …
  • SSM Health Care:企業の戦略的SWOT分析
    SSM Health Care - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆